
On-Demand Content | Virtual Event

Medical Affairs can gather insights to identify clinically meaningful differentiators by engaging with the external community years ahead of launch. These insights can inform clinical strategy and a holistic evidence generation plan that will produce and enhance value substantiation. As the product progresses through its development cycle, the evidence generation priorities and opportunities of the product will evolve. At the prelaunch phase, generating registration data will be prioritized, whereas during launch, generating real world and economic evidence will become more prominent.
SPEAKER HIGHLIGHTS
Top Reasons to Purchase
- Understanding the Value of Real-World Evidence Throughout the Development Stages to Support a Product’s Value
- Developing a Unique KOL Early Engagement Plan to Provide your Product a Critical Competitive Edge
- Involving a Qualified Medical Affairs Team from the Start to Execute a Designed Strategy and Achieve Medical Affairs Goals
- Implement a Well-Planned Strategy to Recruit, Engage and Manage your Medical Affairs Team Effectively.
- Improving Collaboration with R&D to Become a More Strategic Medical Affairs Partner
Who Should Purchase
Pharma, biotech, and medical device company professionals with responsibilities in:
- Medical Science Liaison (MSL)
- Medical Affairs
- Early Stage Medical Affairs
- KOL Relationship Management/ Development
- Opinion/Thought Leader Relations
- External Engagement
- Chief Medical Officer
- Commercial Operations
- Medical and Professional Affairs/Strategy
- Medical and Professional Education
- Scientific/Medical Communication, Relations and Affairs
- MSLs
- Medical Communications
- Scientific Affairs
- Clinical Trials
- Clinical Affairs
- KOL Development
- Scientific Advisor
- Clinical Research
- Medical Education
- Clinical Investigation
- Regulatory Affairs
- Medical Science
- Medical Information Specialist
- Regulatory Affairs
- R&D
- Real World Evidence
SERVICE PROVIDERS
- RWE Solution Providers
- CROs
- Consultancies
On-Demand Content
$195